Dr. Lal Path Labs Ltd. — Updates, 30-04-2026: General Updates
30-04-2026 · 03:37 pm
LALPATHLAB's Board approved FY26 audited financial results. It also declared a final dividend of INR 4/share, acquired Shahbazkers Diagnostic Centre for up to INR 20 Cr, and plans a Dubai subsidiary for strategic investments. Key director re-appointments were also approved.
No comments yet. Be the first to comment!
